NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 871 filers reported holding NOVARTIS A G in Q3 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,730,000 | -1.6% | 29,460 | 0.0% | 1.39% | +4.4% |
| Q3 2014 | $2,773,000 | -11.0% | 29,460 | -14.4% | 1.33% | -12.3% |
| Q2 2014 | $3,115,000 | +0.8% | 34,410 | -5.4% | 1.52% | +0.3% |
| Q1 2014 | $3,091,000 | +22.2% | 36,360 | +15.6% | 1.51% | +25.1% |
| Q4 2013 | $2,529,000 | +3.5% | 31,460 | -1.3% | 1.21% | -10.8% |
| Q3 2013 | $2,444,000 | +7.8% | 31,860 | -0.7% | 1.36% | +2.5% |
| Q2 2013 | $2,268,000 | – | 32,069 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |